Eiger Wealth Management, LLC Diversified Active

Location: San Diego, CA

CIK: 0002161353 · Show all filings

Period: Q1 2026 (← Previous) (Next →)

Filing Date: Nov 3, 2026

Total Value: $3.044M (100.0% shares, 0.0% debt)

Holdings (14)

SCHX Schwab US Large-Cap ETF 27.6%

Value $841K Shares 32,805 Share Price $25.64 Est. Cost/Share $26.71 Unrealized @ Report Date -4.0%

QUAL iShares MSCI USA Quality Factor ETF 12.2%

Value $372K Shares 1,942 Share Price $191.79 Est. Cost/Share $196.49 Unrealized @ Report Date -2.4%

SPY SPDR S&P 500 ETF Trust 10.4%

Value $315K Shares 485 Share Price $650.08 Est. Cost/Share $676.01 Unrealized @ Report Date -3.8%

IMNM Immunome Inc 9.8%

Value $298K Shares 13,647 Share Price $21.87 Est. Cost/Share $17.55 Unrealized @ Report Date +24.6%

VUG Vanguard Growth Index Fund ETF Shares 7.4%

Value $225K Shares 514 Share Price $436.79 * Est. Cost/Share $81.15 Unrealized @ Report Date -10.3%

ZNTL Zentalis Pharmaceuticals Inc 6.6%

Value $201K Shares 86,017 Share Price $2.34 Est. Cost/Share $1.46 Unrealized @ Report Date +60.8%

— GAMCO Natural Resources Gold & Income Trust 6.1%

Value $185K Shares 22,212 Share Price $8.35 Est. Cost/Share $7.45 Unrealized @ Report Date —

— GAMCO Global Gold, Natural Resources & Income Trust 4.7%

Value $143K Shares 26,803 Share Price $5.32 Est. Cost/Share $5.16 Unrealized @ Report Date —

— Morgan Stanley Emerging Markets Domestic Debt Fund, Inc 3.9%

Value $119K Shares 23,510 Share Price $5.07 Est. Cost/Share $5.43 Unrealized @ Report Date —

— Templeton Emerging Markets Income Fund 3.7%

Value $111K Shares 18,500 Share Price $6.01 Est. Cost/Share $6.45 Unrealized @ Report Date —

— FS Credit Opportunities Corp. 3.6%

Value $109K Shares 21,285 Share Price $5.10 Est. Cost/Share $6.30 Unrealized @ Report Date —

— Saba Capital Income & Opportunities Fund II 3.3%

Value $102K Shares 12,250 Share Price $8.32 Est. Cost/Share $8.25 Unrealized @ Report Date —

FATE Fate Therapeutics Inc 0.4%

Value $12,000 Shares 10,000 Share Price $1.20 Est. Cost/Share $1.20 Unrealized @ Report Date -0.1%

QNCX IRULYA THERAPEUTICS INC COM 0.3%

Value $9,552 Shares 94,201 Share Price $0.10 Est. Cost/Share $3.35 Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
SCHX	Schwab US Large-Cap ETF	32,805	$841K	27.6%	$25.64	$26.71	-4.0%	ETF	808524201
QUAL	iShares MSCI USA Quality Factor ETF	1,942	$372K	12.2%	$191.79	$196.49	-2.4%	ETF	46432F339
SPY	SPDR S&P 500 ETF Trust	485	$315K	10.4%	$650.08	$676.01	-3.8%	ETF	78462F103
IMNM	Immunome Inc	13,647	$298K	9.8%	$21.87	$17.55	+24.6%	Stock	45257U108
VUG	Vanguard Growth Index Fund ETF Shares	514	$225K	7.4%	$436.79 *	$81.15	-10.3%	ETF	922908736
ZNTL	Zentalis Pharmaceuticals Inc	86,017	$201K	6.6%	$2.34	$1.46	+60.8%	Stock	98943L107
—	GAMCO Natural Resources Gold & Income Trust	22,212	$185K	6.1%	$8.35	$7.45	—	CEF	36465E101
—	GAMCO Global Gold, Natural Resources & Income Trust	26,803	$143K	4.7%	$5.32	$5.16	—	CEF	36465A109
—	Morgan Stanley Emerging Markets Domestic Debt Fund, Inc	23,510	$119K	3.9%	$5.07	$5.43	—	CEF	617477104
—	Templeton Emerging Markets Income Fund	18,500	$111K	3.7%	$6.01	$6.45	—	CEF	880192109
—	FS Credit Opportunities Corp.	21,285	$109K	3.6%	$5.10	$6.30	—	CEF	30290Y101
—	Saba Capital Income & Opportunities Fund II	12,250	$102K	3.3%	$8.32	$8.25	—	CEF	880198205
FATE	Fate Therapeutics Inc	10,000	$12,000	0.4%	$1.20	$1.20	-0.1%	Stock	31189P102
QNCX	IRULYA THERAPEUTICS INC COM	94,201	$9,552	0.3%	$0.10	$3.35	—	Stock	22053A305